P. Kent Hawryluk

Companies

• MBX Biosciences, Inc.Board member Sep 12, 2024 to now¹
• MBX Biosciences, Inc.Chief executive officer Sep 12, 2024 to Aug 4, 2026¹
• MBX Biosciences, Inc.President Sep 12, 2024 to Aug 4, 2026¹
• MetaVia Inc.Board member Aug 4, 2016 to Jan 30, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MBMBX Biosciences, Inc. MBX1,214,444 shares³$63.8M at $52.51May 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 6, 2026Sold 607 shares at $29.54 of MBX Biosciences, Inc.³
• Mar 13, 2026Bought 18,500 shares at $28.41 of MBX Biosciences, Inc.⁴
• Feb 26, 2026Exercised options 28,768 shares at $16.00 of MBX Biosciences, Inc.⁵
• Feb 2, 2026Granted 35,250 shares of MBX Biosciences, Inc.⁶
• Oct 24, 2025Exercised options 182,859 shares at $3.25 of MBX Biosciences, Inc.⁷
• Oct 20, 2025Bought 20,000 shares at $13.64 of MBX Biosciences, Inc.⁸
• Feb 4, 2025Bought 50,000 shares at $10.69 of MBX Biosciences, Inc.⁹
• Sep 16, 2024Converted 115,914 shares of MBX Biosciences, Inc.¹⁰
• Sep 16, 2024Converted 283,846 shares of MBX Biosciences, Inc.¹⁰